Agc. Milo et al., Clinical and histologic evaluation of an indwelling, inflatable, long-termlaryngeal stent in the canine model, OTO H N SUR, 121(3), 1999, pp. 195-202
OBJECTIVE: The goal was assessment of a revolutionary approach to laryngeal
stenting. A radically designed, atraumatic, inflatable, low-pressure, high
-volume, endoscopically inserted laryngeal stent for effective intralarynge
al support or longterm prevention of aspiration was prospectively evaluated
in a canine model to reveal any significant short- and long-term anatomic
and functional changes in the larynx.
METHODS: A self-sustaining, tube-free, long-term flap tracheostomy was perf
ormed in 14 dogs, followed by endoscopic laryngeal stent insertion. The ste
nts were inflated, and their intraluminal pressures were monitored daily. T
he stenting period ranged between 3 and 46 days (mean 27.4 days). The anima
ls were then euthanized, and total laryngectomy was performed. The larynges
underwent gross and microscopic examinations, and a grading scale of react
ive changes caused by the stent placement was created on the basis of the f
indings.
RESULTS: Dye studies for aspiration were negative in all animals. Gross fin
dings consisted of varying degrees of small ulceration, localized polypoid
lesions, and granulomas. Grossly, 9 dogs exhibited small superficial ulcera
tion of the true vocal cords and posterior commissure. Six dogs developed m
inor polyps or polypoid changes and/or granulomas, respectively. No gross c
hanges were seen in 2 of the dogs. Histopathologically, 10 dogs demonstrate
d grade I or II histopathologic changes. Only 4 of the dogs exhibited infla
mmation extending into the underlying cartilages, grade III. One dog did no
t complete the observation period.
CONCLUSION: This new stent demonstrated safety and biocompatibility with mi
nimal local tissue reaction to its extended long-term placement. Good toler
ance to the stent was documented, with minimal side effects similar to thos
e that would be observed in human subjects after endotracheal intubation. W
hen followed up in human patients, such minimal lesions have not resulted i
n significant long-lasting functional impairments. These initial results wo
uld indicate that this stent is well tolerated for long-term application an
d qualify as the preferred device for both management of aspiration and pos
toperative endolaryngeal bolstering support.